Clal Biotechnology Industries Ltd. (TLV:CBI)

Market Cap	47.21M
Revenue (ttm)	n/a
Net Income (ttm)	-62.46M
Shares Out	156.85M
EPS (ttm)	-0.39
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,515
Average Volume	223,288
Open	30.10
Previous Close	30.30
Day's Range	30.00 - 30.30
52-Week Range	28.20 - 52.50
Beta	0.76
RSI	43.91
Earnings Date	n/a

About TLV:CBI

Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It takes a seat on the board of directors of the companies it invests in. It invests through per...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Country: Israel
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: CBI